SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-097804
Filing Date
2016-04-29
Accepted
2016-04-29 16:15:30
Documents
4
Period of Report
2016-06-14
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A v438124_def14a.htm DEF 14A 347827
2 GRAPHIC image_011.jpg GRAPHIC 104885
3 GRAPHIC image_012.jpg GRAPHIC 90154
4 GRAPHIC tlogo.jpg GRAPHIC 14094
  Complete submission text file 0001144204-16-097804.txt   631067
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 161606759
SIC: 2834 Pharmaceutical Preparations